This news release is intended for media purposes, and is current of the date of publication. Information is subject to change without notice.
September 26, 2017
Kyocera Corporation (President: Hideo Tanimoto) today announced plans to expand operations at its new Medical Development Center, which opened in Japan's Shiga Prefecture at the company's Shiga Yasu Plant in April 2017. The new Medical Development Center integrates medical product manufacturing and R&D operations for Kyocera to aid in future innovations such as wearable and implantable devices.
The Kyocera Group offers a wide range of products and services in the medical sector - including orthopedic / dental implants and electronic components for medical devices. To maximize synergies in device-related businesses, Kyocera Medical Corporation, a former wholly owned subsidiary, was merged into Kyocera Corporation in April this year. As part of the consolidation, Kyocera is currently combining three Japan-based manufacturing operations for medical devices into the Shiga Yasu Plant, and additionally established the Medical Development Center which integrates R&D activities. Through the integration, the company aims to unify manufacturing and R&D operations, and expand business in health and medical markets in a speedy manner.
The company is increasing the development team and accelerating the development of medical products such as wearable and implantable devices by leveraging its expertise as a producer of components. Recent Kyocera developments include a miniaturized blood-flow sensor as well as earbuds with this sensor build in. With the earbuds, the company is developing applications such as monitoring health conditions while listening to music, and is also promoting the development of new devices utilizing the blood-flow sensor. The company is also engaged in a collaborative project with Kyoto University and Osaka University to develop a new cochlear implant. Furthermore, Kyocera Communication Systems Co., Ltd. - a subsidiary which offers information and communications technology (ICT) solutions - recently launched a joint research with the University of Tsukuba to develop an Artificial Intelligence (AI) system capable of detecting skin diseases by analyzing digital images of a patient's skin. Through these projects, the Kyocera Group aims to create various new businesses in the health and medical field.
Kyocera Corporation published this content on 26 September 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 September 2017 03:24:08 UTC.
Original documenthttp://global.kyocera.com/news/2017/0901_bcus.html
Public permalinkhttp://www.publicnow.com/view/EF876CC4F24D42339B8D362136CD42B480F3C578
Kyocera Corporation specializes in the development manufacturing and marketing of electronic components. The group also sells communication, document management, medical and energy systems and equipments. Net sales break down by family of products as follows:
- printing and document management equipments and systems (19.9%);
- electronic components and devices (18.4%) : capacitors, crystal devices, clock oscillators, resonators, connectors, etc.;
- semiconductor components (17.8%);
- communication equipments and systems (14.3%): telecommunications terminals (smartphones, tablets), connectivity devices, telecommunications infrastructure, etc.;
- industrial tools (13.7%);
- automotive and industrial components (10.9%): fine ceramic products (mainly for the manufacture of automotive equipment), liquid crystal displays, optical components, camera modules, etc.;
- other (5%).
Net sales break down geographically as follows: Japan (33.4%), Asia (26.4%), the United States (18.6%), Europe (18.4%) and other (3.2%).
KYOCERA CORPORATION 
